DONALD TAYLOR: Open Payments
NPI 1023127875 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 48 payments from 12 companies in 2025. Trend: 2023 $873 · 2024 $1,090 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $220 |
| Braeburn Inc. | 8 | $174 |
| PFIZER INC. | 7 | $173 |
| Astellas Pharma US Inc | 5 | $112 |
| Axsome Therapeutics, Inc. | 4 | $105 |
| Lundbeck LLC | 4 | $98 |
| Averitas Pharma Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
Products named: SUBLOCADE, CAPLYTA, BRIXADI, NURTEC ODT, Veozah, Symbravo, VYEPTI, QUTENZA.
Industry payments across GA — which companies pay providers there.
